Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices 66269 

Jeffrey M. Zirger, 

Acting Lead, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of Science, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–27852 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–19–0612; Docket No. CDC–2018– 

0111] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

on the Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) program. The 

WISEWOMAN program is designed to 

prevent, detect, and control, 

hypertension and other cardiovascular 

disease risk factors through healthy 

behavior support services, which are 

tailored for individual and group 

behavior change. 

DATES: CDC must receive written 

comments on or before February 25, 

2019. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0111 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

reinstatement of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) (OMB No. 

0920–0612, Exp. 12/31/2018)— 

Reinstatement—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The WISEWOMAN program 

sponsored by the CDC, provides services 

to low income, uninsured, or 

underinsured women aged 40–64. The 

WISEWOMAN program is designed to 

prevent, detect, and control 

hypertension and other CVD risk factors 

through healthy behavior support 

services which are tailored for 

individual and group behavior change. 

The WISEWOMAN program provides 

services to women who are jointly 

enrolled in the National Breast and 

Cervical Cancer Early Detection Program 

(NBCCEDP), which is also administered 

by CDC. 

The WISEWOMAN program is 

administered by state health 

departments and tribal programs. In 

2018, new five-year cooperative 

agreements will be awarded under 

Funding Opportunity Announcement 

DP18–1816, subject to the availability of 

funds. CDC collects two types of 

information from WISEWOMAN 

awardees. The WISEWOMAN awardee 

submits an electronic data file to CDC 

twice per year. The Minimum Data 

Elements (MDE) file contains data using 

a unique identifier with client-level 

information about cardiovascular 

disease risk factors, types of healthy 

behavior support services for 

participants served by the program. The 

estimated burden per response for the 

MDE file is 24 hours. The Annual 

Progress Report provides a narrative 

summary of each awardee’s objectives 

and the activities undertaken to meet 

program goals. The estimated burden 

per response is 16 hours. 

There are no changes to the 

information collected. CDC will 

continue to use the information 

collected from WISEWOMAN awardees 

to support program monitoring and 

improvement activities, evaluation, and 

assessment of program outcomes. The 

overall program evaluation helps to 

demonstrate program accomplishments 

and strengthen the evidence for strategy 

implementation for improved 

engagement of underserved populations. 

It can also determine whether the 

identified strategies and associated 

activities can be implemented at various 

levels within a state or tribal 

organization. Evaluation is also 

designed to demonstrate how 

WISEWOMAN can obtain 

cardiovascular disease health outcome 

data on at-risk populations, promote 

public education about cardiovascular 

disease risk-factors, and improve the 

availability of healthy behavior support 

services for under-served women. 


amozie on DSK3GDR082PROD with NOTICES1
66270 Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices 

OMB approval is requested for three 

years. Participation in this information 

collection is required as a condition of 

cooperative agreement funding. There 

are no costs to respondents other than 

their time. The total annualized burden 

hours are 1,344. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs.) 

Total burden 

(in hrs.) 

WISEWOMAN Awardees .................. Screening and Assessment and 

Lifestyle Program MDEs.

21 2 24 1,008 

Annual Progress Report ................... 21 1 16 336 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,344 

Jeffrey M. Zirger, 

Acting Lead, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of Science, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–27855 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—CK19–002, 

Quantifying Contact Rates and Mixing 

Patterns in Workers in Non-Healthcare Work 

Settings in the United States and CK19–004, 

Study to Assess the Risk of Blood Borne 

Transmission of Classic Forms of CreutzfeldtJakob Disease (CJD). 

Date: May 7, 2019. 

Time: 10:00 a.m.–5:00 p.m., (EDT). 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Gregory 

Anderson, M.S., M.P.H., Scientific Review 

Officer, CDC, 1600 Clifton Road NE, Mailstop 

E60, Atlanta, Georgia 30333, (404) 718–8833, 

gca5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27893 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–19–0600] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled CDC Model 

Performance Evaluation Program 

(MPEP) for Mycobacterium tuberculosis 

Drug Susceptibility Testing to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on August 

28, 2018 to obtain comments from the 

public and affected agencies. CDC 

received one non-substantive 

anonymous comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

CDC Model Performance Evaluation 

Program (MPEP) for Mycobacterium 

tuberculosis Drug Susceptibility Testing 

(OMB Control No.0920–0600, Expires 3/ 

31/2019)—Revision—National Center 

for HIV/AIDS, Viral Hepatitis, STD, and 

TB Prevention (NCHHSTP) Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

As part of the continuing effort to 

support domestic public health 


amozie on DSK3GDR082PROD with NOTICES1